Tablets - 5 mg
Glibenklamid is an oral hypoglycemiant, derivative of the sulfonylurea. The decrease of blood glucose concentration happens because of the stimulation of insulin secretion by the pancreas. This action needs the presence of the beta functional cells.
Glibenklamid is indicated in diabetes mellitus type II (non - insulin dependent diabetes).
Sugar-coated tablets – 10 mg
Oral drops solution – (10.000 UI + 10.000 UI) / ml
Solution for injection - (0.1%) 1 mg/1 ml
Solution for injection - (0.1%) 1 mg/1 ml
Film-coated tablets – 600 mg